Virinchi Ltd. (VIRINCHI) AI Stock Analysis

• Market Cap: ₹2.85B
• Dividend Yield: N/A
• Average Volume (3M): 56.67K
• Price to Earnings (P/E): 4781.0
• Beta (1Y): 0.93
• Revenue Growth: 3.42%
• EPS Growth: -99.48%
• Country: IN
• Employees: 1,033
• Sector: Healthcare
• Sector Strength: 45
• Industry: Software - Application
• EPS (TTM): 0.04
• Shares Outstanding: 102,646,900
• 10 Day Avg. Volume: 105,306
• 30 Day Avg. Volume: 56,666
• PEG Ratio: -3.21
• Price to Book (P/B): 0.47
• Price to Sales (P/S): 0.74
• P/FCF Ratio: -8.73
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹29.00
• Price Target Upside: 2.00% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 61 Neutral
• Price Target: ₹29.00 ▲(2.00% Upside)

Virinchi Ltd.'s overall stock score is driven by financial performance challenges and an unattractive valuation due to a high P/E ratio. Technical analysis shows some positive momentum, but the lack of earnings call data and corporate events limits further insights.

Virinchi Ltd. Business Overview & Revenue Model

Company Description

Virinchi Limited provides information technology (IT) products and services worldwide. The company operates through Development of Computer Software and Services, IT Enabled Services, and Healthcare Services segments. It offers QFund, an IT solution for short-term mortgage and lending industry; vCard, an UPI-based credit card; V23, a healthcare practice management and patient engagement solution; IT services, such as lifecycle management, ECM services, IT infrastructure management, and IT staff augmentation and consulting services; software development; and data science and analysis services. The company also provides media and entertainment, catering, educational, infrastructure, pharmacy supply chain, fintech, healthcare, financial consulting, and short-term lending services. In addition, it owns and manages Virinchi multi-specialty hospitals and Bristlecone Hospitals. The company was formerly known as Virinchi Technologies Limited and changed its name to Virinchi Limited in January 2016. Virinchi Limited was incorporated in 1990 and is headquartered in Hyderabad, India.

How the Company Makes Money

Virinchi Ltd. generates revenue through multiple streams, primarily by providing software solutions and IT services to clients across different industries. Its healthtech division earns income by offering healthcare management systems and solutions to hospitals and healthcare providers, enabling them to streamline their operations and enhance patient care. The fintech segment contributes to revenue by delivering financial technology services and solutions to banks and financial institutions, helping them improve their digital offerings and operational efficiency. Additionally, the company's IT services arm provides consulting, application development, and managed services to businesses, generating income through project-based contracts and long-term service agreements. Virinchi's earnings are also supported by strategic partnerships and collaborations that expand its market reach and enhance its service offerings.

Virinchi Ltd. Financial Statement Overview

Summary

Virinchi Ltd. faces challenges with declining net profit margins and negative free cash flow, despite a stable balance sheet. Operational efficiency and cash management need improvement.

Income Statement

Virinchi Ltd. has shown a challenging revenue performance with a slight increase from 2024 to 2025. The Gross Profit Margin is stable, but Net Profit Margin has seen a sharp decline due to a significant drop in net income. The EBIT and EBITDA margins have also decreased, indicating pressure on operational efficiency.

Balance Sheet

The company maintains a strong equity base with a reasonable Debt-to-Equity Ratio. However, the Return on Equity has decreased significantly, reflecting reduced profitability. The Equity Ratio remains stable, supporting asset-backed equity financing.

Cash Flow

Cash flow from operations remains positive but has decreased from previous years. Free Cash Flow has turned negative, indicating potential issues in covering capital expenditures. The Operating Cash Flow to Net Income Ratio suggests some inefficiencies in converting earnings into cash.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	3.07B	3.01B	3.12B	3.00B	3.64B	3.54B
Gross Profit	1.54B	1.35B	1.93B	1.33B	3.36B	3.31B
EBITDA	1.05B	963.86M	1.11B	1.14B	1.04B	1.02B
Net Income	72.07M	7.24M	128.49M	137.03M	143.05M	27.46M
Balance Sheet
Total Assets	0.00	8.47B	7.87B	8.51B	7.03B	6.87B
Cash, Cash Equivalents and Short-Term Investments	72.50M	77.58M	307.08M	200.25M	366.00M	190.21M
Total Debt	0.00	2.92B	3.17B	3.30B	2.76B	2.61B
Total Liabilities	-4.80B	3.73B	3.80B	3.97B	3.33B	3.12B
Stockholders Equity	4.80B	4.76B	4.08B	4.55B	3.71B	3.76B
Cash Flow
Free Cash Flow	0.00	-253.64M	-377.22M	86.11M	525.18M	-1.04B
Operating Cash Flow	0.00	536.65M	987.00M	1.16B	846.73M	498.55M
Investing Cash Flow	0.00	-778.34M	-1.37B	-1.15B	-336.79M	-1.54B
Financing Cash Flow	0.00	119.01M	323.82M	-127.06M	-334.14M	1.15B

Virinchi Ltd. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 28.43
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VIRINCHI, the sentiment is Neutral. The current price of 28.43 is below the 20-day moving average (MA) of 29.76, below the 50-day MA of 28.87, and above the 200-day MA of 26.06, indicating a neutral trend. The MACD of 0.29 indicates Positive momentum. The RSI at 40.08 is Neutral, neither overbought nor oversold. The STOCH value of 20.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:VIRINCHI.

Virinchi Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BAFNAPH	65 Neutral	₹4.14B	50.13	4.90%	―	2.36%	2924.94%
VIRINCHI	61 Neutral	₹2.85B	4,781.03	―	―	3.42%	-99.48%
AAREYDRUGS	60 Neutral	₹2.23B	53.47	2.91%	―	-4.74%	-35.14%
KREBSBIO	44 Neutral	₹1.52B	-5.62	18.42%	―	-31.91%	-38.46%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Virinchi Ltd. Corporate Events

Virinchi Ltd. Allots 34 Lakh Convertible Equity Warrants

Virinchi Ltd. has announced the allotment of 34,00,000 convertible equity warrants to various public investors at an issue price of Rs. 25 per warrant. This decision follows a special resolution passed by the company’s shareholders and approvals from BSE and NSE. The warrants, issued on a preferential basis, are convertible into equity shares upon payment of the remaining 75% of the issue price. This move does not currently alter the company’s paid-up share capital.